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Abstract
Introduction: Identifying drivers in persistent atrial fibrillation (AF) remains
challenging. We sought to validate an automated system for detection of focal
activation using basket and PentaRay catheters in AF.
Methods: Patients having ablation for atrial tachycardia (AT) and persistent AF were
mapped. Thirty‐second unipolar basket and PentaRay recordings were analyzed using
CARTOFINDER. Focal activation or “region of interest” (ROI) was defined as more than
or equal to 2 consecutive focal activations with one electrode leading relative to its
neighbors with QS morphology on the unipolar electrogram. ROI was validated in AT.
AF patients were mapped to (1) look for evidence of focal activations on wavefront
maps, (2) evaluate whether these were detected as ROI on basket recordings, and
(3) whether these sites could be identified on sequential PentaRay recordings.
Results: ROIs were identified in five focal ATs but none of 16 reentrant ATs. Twenty‐eight
AF patients had 35 focal drivers identified from basket wavefront maps with an ablation
response in all (16 cycle length slowing and 19 AF termination). Thirty focal activations
were detected on basket ROI maps (86%). Twenty‐three of 28 patients had sequential
PentaRay mapping and 22 of 30 focal drivers in these patients (73%) were identified as
ROI. These drivers had greater temporal stability (3.6 ± 0.6 vs 2.7 ± 0.6; P<0.001), higher
recurrence rate (12.4 ±2.7 vs 7.2 ± 0.9; P<0.001), and more frequently were associated
with AF termination (P<0.001) compared with those not identified as ROI.
Conclusions: Focal activations can be detected in AF using sequential recordings. The
ablation response at focal sources suggests they may be viable therapeutic targets.
K E YWORD S
atrial fibrillation, atrial tachycardia, CARTOFINDER mapping, catheter ablation,
focal drivers, rotors
© 2018 The Authors. Journal of Cardiovascular Electrophysiology Published by Wiley Periodicals, Inc.
J Cardiovasc Electrophysiol. 2018;1–9. wileyonlinelibrary.com/journal/jce | 1
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium,
provided the original work is properly cited.
1 | INTRODUCTION
The chaotic nature of persistent atrial fibrillation (AF) has hindered
attempts to identify drivers through sequential mapping. Global
mapping of the left atrium (LA) using different techniques has
identified focal drivers and drivers with rotational activity.1–4
Evaluation of global mapping data to identify intermittent drivers
can be time consuming and subjective. Automated detection of
drivers may facilitate and standardize interpretation of global
mapping data. Furthermore, once validated, it may be possible to
apply a system of automated detection to sequential mapping.
A novel algorithm has been developed as part of the CARTO-
FINDER mapping system that aims to detect repetitive focal
activations automatically. Relevant areas are then highlighted as a
“region of interest” (ROI). However, this algorithm has not been
tested previously and to date no other system has utilized sequential
mapping for automated detection of focal drivers in AF in vivo.
The aim of this study was to (1) validate the CARTOFINDER ROI
algorithm in the automated detection of focal activations by mapping
focal atrial tachycardias (AT), (2) apply this to persistent AF and
correlate sites identified as ROI with focal drivers identified on global
activation mapping with basket catheters, and (3) test the application
of this system to sequential recordings acquired using a PentaRay
catheter, by again comparing the ROI identified to the sites of drivers
identified on global mapping.
2 | MATERIALS AND METHODS
Patients undergoing catheter ablation for persistent AF (< 24 months and
no previous AF ablation) and AT were prospectively included. Patients
provided informed consent for their involvement in this study, and it was
approved by the UK National Research Ethics Service (16/LO/1379).
2.1 | Electrophysiology procedure
All cases were performed with CARTO (Biosense Webster Inc.,
Diamond Bar, CA). LA geometries and detailed bipolar voltage maps
were created using a 2‐6‐2mm spacing PentaRay NAV catheter
(Biosense Webster, Inc) with a color fill threshold of 5 mm aiming for
complete LA coverage. Low‐voltage zones (LVZs) were defined as
sites with a bipolar voltage less than 0.5 mV.5
2.2 | CARTOFINDER global and sequential
mapping
The CARTOFINDER mapping system (Biosense Webster, Inc) was
used to create global dynamic activation maps of the LA using basket
catheters with a minimum of two 30‐second unipolar recordings pre‐
and post‐pulmonary vein isolation (PVI) per patient with the catheter
repositioned between recordings.
CARTOFINDER annotates atrial signals using a system called
“wavelet analysis”6 and from this local activation times (LATs) are
obtained for each electrode. CARTOFINDER filters low quality signals
secondary to noise utilizing an algorithm that looks for a set of different
parameters such as number of atrial beats, signal to noise ratio, signal
amplitude and frequency analysis, and decide if there is enough data to
be used for the annotation algorithm. If not these signals are not
annotated, no timing is assigned and the electrode is ignored. The LATs
are then used to create the global dynamic activation maps.3 Unipolar
recorded using Wilson’s central terminal and signals were filtered at 2
to 240Hz, with a notch filter at 60Hz. No further filtering or processing
was applied. Filtering was kept consistent between all patients.
CARTOFINDER was also used to map the LA with sequential
PentaRay catheter recordings aiming for even LA coverage with a
minimum of 10 recordings per patient. Care was taken to ensure the
best possible electrode contact and spacing between the PentaRay
catheter splines.
The main aim of the study was to map the repetitive focal activations
in the LA. The right atrium was not mapped in any of these patients.
2.3 | Ablation strategy
All patients underwent wide area circumferential ablation to achieve
PVI using a Thermocool SmartTouch Surround Flow catheter
(Biosense Webster, Inc). The global dynamic activation maps were
then prospectively reviewed by the two operators with the aim to
identify and ablate repetitive focal activations that were defined as
more than or equal to 2 consecutive focal discharges with radial
spread.3,7,8 As the focus of this study was focal drivers, rotational
drivers were not scrutinized further in this analysis.
Ablation at the repetitive focal activation site, as guided by the
global activation maps was performed 20minutes post‐PVI to minimize
the impact of PVI on the ablation response seen at the focal site.
Ablation was delivered with a contact force of 5 to 40 g and a power of
30 to 40W. Ablation was initially performed at the center of the focal
site with further consolidating lesions around the center. Ablation was
continued until (1) a predefined ablation response was achieved
(termination of AF or cycle length [CL] slowing of ≥30ms); (2) no signal
was present at the driver site; or (3) 5minutes of ablation had been
performed at each site. Beyond isolating PVs and targeting repetitive
focal activations no additional ablation was performed in AF. If the AF
organized into an AT this was mapped and ablated.
AF CL was measured preablation and postablation over 30 cycles
from the bipole pair with the clearest electrogram on the PentaRay
catheter that was positioned in the LA appendage. In a patient who may
have multiple potential drivers it would seem important to note any
marked response to ablation. So as to note only a marked response to
ablation a significant change in AF CL was defined as more than or equal
to 30milliseconds as we have used in other recent studies.3,8
2.4 | ROI analysis
ROI maps were processed offline using an automated driver
detection method to identify repetitive focal activations. The
automated method required (1) demonstration of a QS morphology
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on the unipolar recording; (2) the atrial signal with QS morphology
needs to be earlier than its neighboring electrodes; and (3)
completing two consecutive repetitions. The repetitive focal activa-
tions were referred to as ROI sites and were highlighted on the LA
geometry.
(1) Validation of the ROI system in the detection of focal activations
in AT ROI maps using basket catheters were created in patients
undergoing AT ablation. Conventional LAT maps, entrainment
and ablation response then verified the AT mechanism. The
identification of an ROI site was related to the presence of a focal
versus reentrant mechanisms of AT. In those with focal AT, the
location of these ROI sites were compared with the sites of focal
activity on activation mapping.
(2) Identification of ROI in AF during global and sequential mapping.
The ROI sites identified on maps created with the basket catheter
were compared offline to the global activation maps that were used
to guide ablation of repetitive focal activations. Two observers that
were blinded to the findings of the global maps performed the
analysis to confirm whether sites identified as ROI met the necessary
criteria. The electrode identified as an ROI site was then correlated
to the site of the focal driver identified and marked on CARTO as a
“location only” point by the two operators live during cases and the
sites were said to correlate if the they measured less than 1 cm
center to center measured using the distance measurement tool on
CARTO. ROI sites identified on sequential PentaRay recordings were
likewise compared with focal driver sites that had been identified and
ablated using global activation maps generated from basket
recordings.
The characteristics of the focal drivers that were identified as
ROI were compared to those that were not. The driver character-
istics included (1) consistency, the proportion of global maps that
show the same repetitive focal activation; (2) temporal stability,
average consecutive repetitions of a focal activation during a 30‐
second recording; (3) recurrence rate, number of times a focal driver
met the definition of a driver during a 30‐second recording.
2.5 | Outcomes
Patients were followed up at 3, 6, 9, and 12 months with 48 hours of
ambulatory Holter monitoring at 6 and 12months and further monitoring
dictated by symptoms. Success was defined as freedom from AF or atrial
tachyarrhythmias lasting more than 30 seconds off antiarrhythmic drugs
after a 3‐month blanking period as per current guidelines.9
2.6 | Statistical analysis
Statistical analyses were performed using SPSS (IBM SPSS Statistics,
Version 24; IBM Corp, New York, NY). Continuous variables are
displayed as mean ± standard deviation (SD) or median (range).
Categorical variables are presented as a number and percentage. The
Student t test or the Mann‐Whitney U test was used for comparison
of continuous variables. Sensitivity and specificity was determined
for the ROI algorithm in terms of its ability to identify focal drivers.
P < 0.05 was deemed as significant.
3 | RESULTS
Fifty patients were included (34 patients undergoing ablation for
persistent AF and 16 for AT) (Table 1).
3.1 | Validation of the ROI system in the detection
of focal activations in AT
Twenty‐one ATs were mapped in the 16 AT patients (Figure 1) out of
which five were focal (n=2 anterior LA, n=1 low posterior LA, n=1 low
anteroseptal LA, and n=1 LA roof) in five patients. In these five patients,
15 simultaneous CARTOFINDER maps were created with a single ROI
electrode identified on all maps correlating to the site of the focal AT as
per the conventional LAT map (Figure 2A‐C). Manually reviewing the
7.5minutes of unipolar recordings the criteria for ROI was consistently
met as the AT cycle repeated itself. No ROI were identified on the 35
maps of the 16 microreentrant and macroreentrant ATs.
3.2 | Mapping and ablation of repetitive focal
activations in AF
In the 34 patients undergoing persistent AF ablation, 226 global
activation wavefront maps were created in the LA (116 pre‐PVI and
110 post‐PVI, 3.3 ± 0.7 maps per patient at each stage).
Twenty‐eight of the 34 patients (82%) had a repetitive focal
activation mapped and ablated as determined on 139 of the 226
(62%) global maps and 79 of the 110 post‐PVI global maps (72%).
Thirty‐five repetitive focal activations were identified in the 28
patients (1.3 ± 0.4 per patient) with a predefined ablation response in
all making them all drivers (20 repetitive focal activations [57%]
resulted in AF termination in 20 patients [71%]) (Figure 1 and
Supporting Information Table 2).
Focal drivers showed a mean of 11.1 ± 3.7 occurrences during a
30‐second recording and with 3.2 ± 0.8 consecutive repetitions at
each occurrence. Drivers most often occurred for a mean of 2 to 3
consecutive repetitions (14/35, 40%). The proportion of drivers that
occurred with a mean consecutive repetition of more than 3 to 4 and
more than 4 to 5 were 16/35 (46%) and 5/35 (14%), respectively.
Drivers that showed greater recurrence rate (12.2 ± 3.1 vs 8.4 ± 2.1;
P <0.001) and higher temporal stability (3.6 ± 0.6 vs 2.7 ± 0.6; P < 0.001)
were more commonly associated with AF termination compared with
CL slowing. Focal drivers that were seen on pre‐PVI maps were also
more commonly associated with AF termination compared to CL
slowing (16 of 20 focal drivers resulting in AF termination were seen on
pre‐PVI maps vs 5 of 15 drivers causing CL slowing were seen on pre‐
PVI maps; P =0.01). There was no significant difference in the LA
appendage CL between cases that resulted in AF termination vs CL
slowing with ablation (142.5 ± 22.3 vs 145.8 ± 32.4; P =0.67).
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Focal drivers were distributed throughout the LA but more
commonly mapped to the roof (14 of 35, 40%) followed by the lateral
wall (8 of 35, 23%). The drivers did not show a predilection to LVZs with
equal distribution in LVZs (19 of 35, 54%) and non‐LVZs (16 of 35, 46%).
3.3 | Identification of ROI in AF during global and
sequential mapping
There was 100% interobserver agreement between the two
operators regarding whether the ROI sites correlated with sites of
focal activation on the global activation maps. Subsequent review by
both operators showed that intraobserver agreement was also 100%.
3.3.1 | Global activation maps
ROI sites were identified on 121 of 139 global activation maps (87%)
and on 58 of 79 post‐PVI global activation maps (79%). Twenty‐five
of 28 patients (89%) had a ROI site identified. Manual analysis of the
unipolar signals at the ROI site confirmed that these sites met the
criteria of a ROI site (Figures 3A‐C and 4A‐C). ROI sites were not
identified in the six patients in whom repetitive focal activations
were not seen on the global maps. Supporting Information Table 1
shows details of each focal driver and whether it was detected as an
ROI. Eight ROI maps (8/73, 11%) in four patients showed ROI sites
that did not correlate to driver sites on global wavefront maps. These
additional sites occurred in patients in whom the focal driver ablation
response was CL slowing.
F IGURE 1 Flow diagram highlighting the mapping procedure in
the persistent AF and AT patients and the number of drivers
identified on the dynamic wavefront and ROI maps with
simultaneous and sequential mapping. AF, atrial fibrillation; AT, atrial
tachycardia; ROI, region of interest
TABLE 1 Patient demographics
Baseline characteristics AT patients, n = 16 AF patients, n = 34
Age, y, mean ± SD 59.8 ± 13.0 59.2 ± 10.5
Male, n (%) 10 (63) 24 (71)
Diabetes mellitus, n (%) 0 1 (3)
Hypertension, n (%) 7 (44) 9 (26)
TIA/CVA, n (%) 0 1 (3)
Ischemic heart disease, n (%) 0 2 (6)
Cardiac surgery, n (%) 1 (6) 0
Left ventricular EF ≥ 55%, n (%) 14 (88) 30 (88)
LA area, cm2, mean ± SD 25.4 ± 3.9 26.0 ± 3.8
Bipolar voltage, mV, mean ± SD 0.31 ± 0.10 0.45 ± 0.16
AF duration, mo, mean ± SD – 14.6 ± 4.6
Previous ablation, n (%)
AF 14 (88) 0
Cavotricuspid isthmus dependent flutter 2 (13) 1 (3)
Current medical strategy
Calcium channel blocker 0 2 (6)
Beta-blockers including sotalol 16 (100) 20 (59)
Amiodarone 0 23 (68)
Flecainide 1 (6) 1 (3)
Current anticoagulation strategy
Warfarin 13 (81) 5 (15)
Direct‐acting oral anticoagulants 3 (19) 29 (85)
Abbreviations: EF, ejection fraction; TIA/CVA, transient ischemic attack/cerebrovascular attack.
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F IGURE 2 A focal AT mapped to the LA septum as indicated on (A) ROI map in a titled AP view created with simultaneous mapping with
basket catheter. (B) Corresponding unipolar electrograms with the green electrode highlighting the ROI site and the arrows highlighting radial
spread from this site. (Ci‐ii) conventional LAT map in a titled AP and right lateral view demonstrating the earliest activation site correlating to
the ROI site. (D) Electrograms obtained from data points on CARTO during the creation of the LAT map with points on either side of the red
area timing later. AP, anterioposterior; AT, atrial tachycardia; LA, left atrium; LAT, left atrial thrombus; LUPV, left upper pulmonary vein; ROI,
region of interest; RUPV, right upper pulmonary vein
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3.3.2 | Sequential activation maps
Twenty‐eight of the 34 patients (82%) had sequential mapping
performed with the PentaRay catheter with a total of 367 recordings
(13.1 ± 1.6 recordings per patient). Out of the 28 patients that had a
focal driver identified, 23 had sequential mapping performed (82%)
corresponding to 303 recordings (13.2 ± 1.6 maps per patient).
Twenty‐five ROI sites were identified in the 23 patients out of
which 22 correlated to the site of one of the 30 focal drivers (73%)
identified in these patients. The drivers that were identified on the
sequential ROI maps showed greater consistency (86.9 ± 15.1 vs
F IGURE 3 Demonstrates sites identified as ROI located at different LA anatomical surfaces in three different patients: (A) roof/LA
appendage, (B) posterior‐inferior wall, (C) anterior LA appendage. Ablation at site (A) and (C) resulted in AF termination while at site (B) ablation
resulted in CL slowing. It also shows the corresponding unipolar electrograms at the ROI site that confirms that all the sites meet the criteria of
a ROI site (≥2 focal activations in which one electrode led relative to its neighbors with QS morphology on unipolar electrograms). LAA, left
atrial appendage; LUPV, left upper pulmonary vein; RUPV, right upper pulmonary vein
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71.0 ± 19.4% of maps; P = 0.02), a higher recurrence rate (12.4 ± 2.7
vs 7.2 ± 0.9; P < 0.001) and temporal stability (3.7 ± 0.5 vs 2.3 ± 0.1;
P < 0.001) compared with drivers that were not identified. Further to
this, these drivers were more frequently associated with AF
termination compared to CL slowing (termination with ablation of
17 of 22 drivers identified on sequential ROI maps vs 0 of 8 not
identified on sequential ROI maps; P < 0.001). Table 2 demonstrates
the accuracy of the ROI algorithm when using global or sequential
mapping. Figure 5A‐E demonstrates a focal driver mapped to the
inferolateral LA on the global wavefront maps that correlated to ROI
sites identified with global and sequential mapping.
3.4 | Ablation performed
The total radiofrequency (RF) time was 68.5 ± 16.4 minutes. The RF
ablation time to achieve PVI was 41.6 ± 14.8 minutes and the mean
RF time to target focal driver sites was 5.2 ± 3.2 minutes The average
time spent at each focal driver site was 2.9 ± 1.5 minutes.
3.4.1 | Outcome
During an average follow‐up of 16.3 ± 3.7 months, 24 of 34 patients
were free from AF/AT (70.6%) off antiarrhythmic drugs. Of the 10
with recurrent arrhythmia, six had AT and four had recurrent AF.
4 | DISCUSSION
This is the first study to utilize a novel mapping algorithm created to
identify focal drivers during endocardial mapping of AF. The
CARTOFINDER system consistently identified sites of focal AT as
ROI, without false positives in those patients with reentrant AT.
Repetitive focal activations were identified in AF on global wavefront
maps created with basket recordings, a majority of which were
identified by the automated system as ROI. Application of the system
to sequential PentaRay recordings showed that a majority of sites
with repetitive focal activations were identified as ROI. Focal drivers
that were detected on sequential PentaRay recordings were more
consistent, showed greater temporal stability and a higher recur-
rence rate compared with drivers that were not identified as ROI.
Ablation at the sites of repetitive focal activations identified as ROI
on sequential PentaRay maps was more likely to terminate AF than
drivers identified on global wavefront maps alone.
4.1 | Use of the ROI algorithm to detect repetitive
focal activations in AF
The ROI algorithm showed a high sensitivity and specificity in the
identification of focal drivers utilizing either global basket recordings or
sequential PentaRay recordings. In four patients, additional ROI sites
were identified that did not correlate to focal drivers on the global
maps. It is unclear whether this was a “false positive,” or a genuine focal
driver that was not identified on the global wavefront map. In all four
patients the ablation response at other sites was CL slowing rather than
AF termination. Without having targeted the additional ROI sites
prospectively, their mechanistic importance remains unclear.
Several studies describing focal drivers in persistent AF have done
so through analysis of wavefront maps.1–5 However, scrutinizing
multiple 30‐second dynamic wavefront maps and then reviewing these
in different orientations can be time consuming. Interpreting maps has a
learning curve and there may be some subjectivity when identifying
F IGURE 4 A focal driver mapped to the lateral wall on (Ai‐iv) still CARTOFINDER wavefront maps, (B) ROI map created with simultaneous
mapping with basket catheter, and (C) corresponding unipolar electrograms recorded on the basket catheter with the green electrogram
highlighting the ROI electrode. LAA, left atrial appendage; LUPV, left upper pulmonary vein; ROI, region of interest
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drivers through visual inspection of dynamic wavefront maps. Applica-
tion of the ROI algorithm to global basket recordings may facilitate
interpretation of maps, speeding up the process of visual analysis by
allowing the operator to focus scrutiny on a ROI and bringing some
objectivity at least to the provisional identification of focal driver sites.
4.2 | Mapping focal activations in AF
Epicardial mapping studies have demonstrated approximately two to
four focal drivers per patient, albeit including single focal activa-
tions.10 However, in this endocardial mapping study a majority of
patients had only one focal driver mapped with an average of
1.3 ± 0.4 per patient. This is consistent with the findings of previous
endocardial mapping studies.1,11 In this study a site of repetitive focal
activations was defined as a driver only if there was a predefined
ablation response. In contrast, in these epicardial‐mapping studies,
the focal activations identified were not ablated and therefore it is
unclear whether all of these were mechanistically important.
Although the ablation response suggests that these drivers were
not “false positives,” it is possible that further focal drivers went
undetected using our methodology.
In this study focal drivers were mapped to the LA body with no
drivers identified within the PVs. This is consistent with other studies
where patients with an AF duration of more than 12 months (as in
this study) were associated with increased extra PV drivers.12 It is of
course possible that focal drivers at the conical PV ostia were missed
by mapping the body of the LA with a spherical basket catheter.
Regardless the PVs were isolated at the start and hence any drivers
missed were still addressed with this strategy. It is unclear though
whether a strategy targeting ROI without first isolating the PVs
might leave undetected PV foci unaddressed.
4.3 | Identification of repetitive focal activations
on sequential mapping
Sequential high‐resolution epicardial mapping has demonstrated
wavefronts arising from a focus meeting similar criteria to that
used by the ROI algorithm.11 Focal activations have been
identified on epicardial mapping in AF in other studies.13 It has
been argued that other epicardial mapping studies that have failed
to identify focal drivers during sequential mapping14 may have
been hindered by insufficient LA coverage or too limited a
recording period. This is the first study to systematically
investigate whether focal drivers can be identified through
sequential endocardial mapping in vivo. There was an increased
likelihood of focal drivers being identified on sequential mapping if
TABLE 2 Identification of focal drivers as ROI using different mapping modalities
Identifying a focal driver on the
dynamic wavefront maps Sensitivity %, 95% CI Specificity %, 95% CI
Positive predictive
value %, 95% CI
Negative predictive
value %, 95% CI
ROI maps with global basket
mapping
79 (68‐88) 87 (76‐94) 88 (77‐94) 79 (67‐82)
ROI maps with sequential PentaRay
mapping
73 (54‐88) 99 (97‐100) 88 (70‐96) 97 (95‐99)
Only assessing drivers associated
with termination
81 (58‐95) 98 (96‐99) 77 (58‐89) 98 (95‐99)
Abbreviations: CI, confidence interval; ROI, region of interest.
F IGURE 5 A focal driver mapped to inferior‐posterior wall on (Ai‐iii) still CARTOFINDER wavefront maps, (B) ROI map created with
simultaneous mapping with basket catheter, (C) ROI map created with sequential mapping with PentaRay catheter, (D) corresponding unipolar
electrograms recorded on PentaRay with the electrogram in green highlighting the electrode recording the initial signal at the focal driver site
with radial spread to the surrounding electrodes. (E) Unipolar electrograms recorded on PentaRay between episodes of repetitive focal
activations. (F) Electrograms demonstrating AF termination to sinus rhythm during ablation at the driver site. AF, atrial fibrillation; LUPV, left
upper pulmonary vein; ROI, region of interest; RUPV, right upper pulmonary vein
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the driver showed greater consistency, higher temporal stability
and recurrence rate. Furthermore, ablation of focal drivers
identified as ROI on sequential mapping was more likely to
terminate AF than those not identified in this way. This is intuitive;
the more often a focal driver occurs the more likely it is to (a) be
mechanistically important and (b) be detected. Focal drivers may
be more stable than drivers with rotational activity.2–4 Further-
more, the core of rotational drivers can occupy a large area2 that
may be difficult to map with sequential recordings. Therefore,
sequential mapping of localized drivers in AF may lend itself better
to identification of focal drivers than rotational activation
patterns. Further attempts to identify these mechanisms using
different methodologies will clarify this.
5 | LIMITATIONS
One of the study limitations is the small patient numbers. However,
having assessed 35 focal drivers across 139 CARTOFINDER maps,
these data have allowed effective evaluation of the ROI algorithm
with simultaneous and sequential mapping.
The study aim was to validate the ROI algorithm in the detection
of focal drivers and apply this to AF. However, at the time of writing
the ROI algorithm could not be applied prospectively in real‐time.
Further work is needed to apply the ROI algorithm prospectively and
study the ablation response guided by this and ultimately study the
clinical impact in a larger cohort.
6 | CONCLUSIONS
The ROI algorithm can effectively identify focal sources in AF using
either basket or sequential PentaRay recordings. The ablation
response of these focal sources suggests that they are mechan-
istically important and may be a viable therapeutic target in
persistent AF ablation. Prospective studies targeting these sites are
needed to evaluate the clinical impact.
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